Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Erbliche Fettstoffwechselerkrankungen

Der Gruppe der erblichen Fettstoffwechselerkrankungen umfasst Störungen des Fettgewebes wie auch Dyslipidämien, deren Ursache in anderen Organen oder Geweben zu suchen ist.

Gliederung

Erbliche Stoffwechselerkrankungen
Coenzym Q10-Mangel
Erbliche Fettstoffwechselerkrankungen
Dyslipidämie
Apolipoprotein-Mangel
APOA5
APOB
APOC1
APOC2
APOC3
APOE
APOL1
APOM
Apolipoprotein A1-Mangel
APOA1
Apolipoprotein A2-Mangel
APOA2
Apolipoprotein F-Mangel
APOF
Apolipoprotein H-Mangel
APOH
CLU
Betalipoprotein-Mangel
Abetalipoproteinämie
MTTP
Hypobetalipoproteinemie
ANGPTL3
APOB
Epigenetische Dyslipidämie
ABCG1
CPT1A
MIR33B
SREBF1
TNIP1
TNNT1
Hyperalphalipoproteinämie 1
CETP
Hyperalphalipoproteinämie 2
APOC3
Hyperlipämie
Chylomikronämie
ABCA1
ABCG5
APOA5
APOC2
APOE
Chylomikronen-Retentions-Krankheit
SAR1B
GPIHBP1
LCAT
LIPA
LIPC
LMF1
LPL
SAR1B
Familiäre kombinierte Hyperlipämie
Kombinierte familiäre Hyperlipämie mit Dysfunktion des Fettgewebes
C5AR2
CREB3L3
LEPR
LIPE
PNPLA2
PPARG
USF1
Kombinierte familiäre Hyperlipämie mit VLDL-Überproduktion
APOE
GCKR
OSBPL10
USF1
Kombinierte familiäre Hyperlipämie mit gestörtem VLDL-Metabolismus
ANGPTL8
APOA1
APOA4
APOA5
APOC3
CETP
GALNT2
LCAT
LIPC
LIPG
LPL
RXRG
USF1
Kombinierte familiäre Hyperlipämie mit gestörter LDL-Clearance
ATF6
LDLR
PCSK9
Hypercholesterinämie
Autosomal dominante Hypercholesterinämie 1
LDLR
Autosomal dominante Hypercholesterinämie 2
APOB
Autosomal dominante Hypercholesterinämie 3
PCSK9
Autosomal rezessive Hypercholesterinämie
LDLRAP1
Lp(a) Hyperlipoproteinämie
LPA
Veranlagung für hohes LDL-Cholesterin
HMGCR
Hypertriglyceridämie
APOA5
APOE
GPIHBP1
Kombinierter Lipasemangel
LMF1
LIPC
LIPE
LPL
Transiente infantile Hypertriglyceridämie
GPD1
Veranlagung für hohe Triglyceridwerte
ANGPTL4
Mangel an lysosomaler saurer Lipase
LIPA
Hypoalphalipoproteinämie
ABCA1
APOA1
Hypobetalipoproteinemie
ANGPTL3
APOB
Gestörte Regulatoren des Lipid- und Kohlenhydratstoffwechsels
GCKR
GPD1
MLXIPL
TRIB1
Hepatischer CPT-Mangel Typ 1A
CPT1A
Meerblaue Histiozytenerkrankung
APOE
Statin-Intoleranz
SLCO1B1
Störung der Körperfettverteilung
Fettleibigkeit
Autosomal dominante Adipositas
MC4R
BMI-beeinflussender genetischer Faktor
Genetischer BMI-Faktor 14
FTO
Frühzeitig einsetzende Adipositas
NR0B2
POMC
Neigung zu Fettleibigkeit
ADRB2
ADRB3
CARTPT
ENPP1
GHRL
PPARGC1B
SDC3
UCP1
Schwere Fettsucht
PPARG
SIM1
Schwere Fettsucht mit Typ 2 Diabetes
UCP3
Spätmanifeste Adipositas
AGRP
Lipodystrophie
Chronische atypische neutrophile Dermatose mit Lipodystrophie und erhöhter Temperatur
PSMA3
PSMB4
PSMB8
PSMB9
PSMG2
Generalisierte Lipodystrophie
Generalisierte Lipodystrophie Typ 1
AGPAT2
Kongenitale progressive Lipodystrophie Typ 2
BSCL2
Partielle Lipodystrophie
Familiäre partielle Lipodystrophie Typ 2
LMNA
Familiäre partielle Lipodystrophie Typ 3
PPARG
Familiäre partielle Lipodystrophie Typ 4
PLIN1
Familiäre partielle Lipodystrophie Typ 5
CIDEC
Vererbte Magersucht
AGRP
Störungen der mRNA-Editiertfunktion
APOBEC1
APOBEC2
APOBEC3A
APOBEC3B
APOBEC3C
APOBEC3D
APOBEC3F
APOBEC3G
APOBEC3H
APOBEC4
Tangier Erkrankung
ABCA1
Triglyceridspeicherkrankheit
Triglyceridspeicherkrankheit mit Ichtiosis
ABHD5
Triglyceridspeicherkrankheit mit Myopathie
PNPLA2
Vermindete Cholesterinsenkung durch Statine
HMGCR
KIF6
Genetisch bedingte Hyperbilirubinämie
Glycolipidose
HADH-Mangel
Hereditäre Störungen des Proteinmetabolismus
Hyperkatabole Hypoproteinämie
Hyperzinkämie und Hypercalprotectinämie
Hypomagnesiämie
Hypomethylierungs-Syndrom
Kongenitale Glykosilierungsstörung
Lebensmittelunverträglichkeiten
Lysosomale Speicherkrankheiten
MELAS-Syndrom
Methioninadenosyltransferase-Mangel
Methylmalonazidurie
Störungen des Cobalaminstoffwechsels
Störungen des Eisenstoffwechsels
Störungen des Glucosestoffwechsels
Störungen des Harnstoffzyklus
Störungen des Harnsäurestoffwechsels
Störungen des Phosphathaushaltes

Referenzen:

1.

Takada D et al. (2002) Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.

external link
2.

Allayee H et al. (2003) Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.

external link
3.

Hayden MR et al. (1987) DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.

external link
4.

Karathanasis SK et al. () Linkage of human apolipoproteins A-I and C-III genes.

external link
5.

Lindgren V et al. (1985) Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes.

external link
6.

Cuchel M et al. (2007) Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

external link
7.

Pajukanta P et al. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).

external link
8.

Putt W et al. (2004) Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

external link
9.

Takada D et al. (2003) Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred.

external link
10.

Musunuru K et al. (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.

external link
11.

Pulai JI et al. (1998) Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families.

external link
12.

Kao JT et al. (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.

external link
13.

Varret M et al. (1999) A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32.

external link
14.

Hunt SC et al. (2000) Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred.

external link
15.

Abifadel M et al. (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

external link
16.

Timms KM et al. (2004) A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree.

external link
17.

Cohen J et al. (2005) Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

external link
18.

Brunzell JD et al. (1983) Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

external link
19.

Zuliani G et al. (1999) Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia.

external link
20.

Haddad L et al. (1999) Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.

external link
21.

Norman D et al. (1999) Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.

external link
22.

Ciccarese M et al. (2000) A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26.

external link
23.

Eden ER et al. (2001) Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families.

external link
24.

Garcia CK et al. (2001) Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein.

external link
25.

Al-Kateb H et al. (2002) Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia.

external link
26.

Canizales-Quinteros S et al. (2005) A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia.

external link
27.

Jones C et al. (2007) Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

external link
28.

Zuliani G et al. (1995) Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree.

external link
29.

Rallidis L et al. (1996) Aortic stenosis in homozygous familial hypercholesterolaemia.

external link
30.

Sun XM et al. (1997) Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group.

external link
31.

Schmidt HH et al. (1998) Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.

external link
32.

Yuan B et al. (2000) Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22.

external link
33.

Sherva R et al. (2007) Evidence for a quantitative trait locus affecting low levels of apolipoprotein B and low density lipoprotein on chromosome 10 in Caucasian families.

external link
34.

Heaney AP et al. (1999) Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.

external link
35.

BOGGS JD et al. (1957) The genetic mechanism of idiopathic hyperlipemia.

external link
36.

HAVEL RJ et al. (1960) Idiopathic hyperlipemia: metabolic studies in an affected family.

external link
37.

Kawashiri MA et al. (2005) Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

external link
38.

Henderson HE et al. (1991) Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.

external link
39.

Sternowsky HJ et al. (1977) Juvenile familial hypertriglyceridemia and growth retardation. Clinical and biochemical observations in three siblings.

external link
40.

Emi M et al. (1990) Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency.

external link
41.

None (1937) Splenomegaly with Lipaemia.

external link
42.

Auwerx JH et al. (1989) Defective enzyme protein in lipoprotein lipase deficiency.

external link
43.

None (1989) Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

external link
44.

None (1987) An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.

external link
45.

Nevin NC et al. (1968) Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.

external link
46.

Breckenridge WC et al. (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

external link
47.

Wessler S et al. (1969) Classification and management of familial hyperlipoproteinemia.

external link
48.

Hoeg JM et al. (1983) Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.

external link
49.

Brunzell JD et al. (1980) Heterogeneity of primary lipoprotein lipase deficiency.

external link
50.

Cantin B et al. (1995) Hemolysis in primary lipoprotein lipase deficiency.

external link
51.

Feoli-Fonseca JC et al. (1998) Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.

external link
52.

None (1991) Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada).

external link
53.

Hobbs HH et al. (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.

external link
54.

Frank SL et al. (1989) Linkage of the mouse LDL receptor gene on chromosome 9.

external link
55.

Miyake Y et al. (1989) Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia.

external link
56.

Brink PA et al. (1987) Familial hypercholesterolemia in South African Afrikaners. PvuII and StuI DNA polymorphisms in the LDL-receptor gene consistent with a predominating founder gene effect.

external link
57.

Steyn K et al. (1989) The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.

external link
58.

Knight BL et al. (1989) Defective processing and binding of low-density lipoprotein receptors in fibroblasts from a familial hypercholesterolaemic subject.

external link
59.

Hobbs HH et al. (1986) Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.

external link
60.

Komuro I et al. (1987) The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor.

external link
61.

Kotze MJ et al. (1987) Haplotype associations of three DNA polymorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolaemia.

external link
62.

Horsthemke B et al. (1987) Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia.

external link
63.

Lehrman MA et al. (1985) Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain.

external link
64.

Davis CG et al. (1986) The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.

external link
65.

Brown MS et al. (1974) Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.

external link
66.

Goldstein JL et al. (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

external link
67.

Kingsley DM et al. (1984) Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity.

external link
68.

Torrington M et al. (1981) Familial hypercholesterolaemia and church affiliation.

external link
69.

Tolleshaug H et al. (1982) Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia.

external link
70.

Francke U et al. (1984) Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

external link
71.

Allen JM et al. (1980) Cadiovascular complications of homozygous familial hypercholesterolaemia.

external link
72.

Seftel HC et al. (1980) A host of hypercholesterolaemic homozygotes in South Africa.

external link
73.

Grossman M et al. (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia.

external link
74.

Feussner G et al. (1996) Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.

external link
75.

Vergopoulos A et al. () A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.

external link
76.

Defesche JC et al. (1998) Molecular epidemiology of familial hypercholesterolaemia.

external link
77.

Ekström U et al. (1999) An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F).

external link
78.

Knoblauch H et al. (2000) A cholesterol-lowering gene maps to chromosome 13q.

external link
79.

Durst R et al. (2001) Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

external link
80.

Vergotine J et al. (2001) Prenatal diagnosis of familial hypercholesterolemia: importance of DNA analysis in the high-risk South African population.

external link
81.

None (1964) THE INHERITANCE OF ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA.

external link
82.

Sato K et al. (2004) Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.

external link
83.

Bourbon M et al. (2007) A rare polymorphism in the low density lipoprotein (LDL) gene that affects mRNA splicing.

external link
84.

Defesche JC et al. (2008) Silent exonic mutations in the low-density lipoprotein receptor gene that cause familial hypercholesterolemia by affecting mRNA splicing.

external link
85.

Kulseth MA et al. (2010) Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site.

external link
86.

Yang WS et al. (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.

external link
87.

Knouff C et al. (2001) Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform.

external link
88.

Aouizerat BE et al. (1999) A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

external link
89.

Geurts JM et al. (2000) Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.

external link
90.

Bodnar JS et al. (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1.

external link
91.

Brunzell JD et al. (1976) Myocardial infarction in the familial forms of hypertriglyceridemia.

external link
92.

Pajukanta P et al. (2003) Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q.

external link
93.

van der Vleuten GM et al. (2004) Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.

external link
94.

Wojciechowski AP et al. (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.

external link
95.

Nishina PM et al. (1992) Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19.

external link
96.

Rauh G et al. (1990) Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.

external link
97.

Ito Y et al. (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

external link
98.

Babirak SP et al. () Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.

external link
99.

None (1989) Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs.

external link
100.

Rose HG et al. (1973) Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

external link
101.

Kissebah AH et al. () Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.

external link
102.

Chait A et al. (1983) Severe hypertriglyceridemia: role of familial and acquired disorders.

external link
103.

Xu CF et al. (1994) Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.

external link
104.

Rotter JI et al. (1996) Multilocus genetic determinants of LDL particle size in coronary artery disease families.

external link
105.

Bredie SJ et al. (1996) Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.

external link
106.

Masucci-Magoulas L et al. (1997) A mouse model with features of familial combined hyperlipidemia.

external link
107.

Bredie SJ et al. (1997) Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity.

external link
108.

Wijsman EM et al. (1998) Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex.

external link
109.

Pajukanta P et al. (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.

external link
110.

Castellani LW et al. (1998) Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.

external link
111.

Juo SH et al. (1998) A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.

external link
112.

Allayee H et al. (1998) Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

external link
113.

Duggirala R et al. (2000) A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans.

external link
114.

Marsh L et al. (2000) Treatment of early Parkinson's disease.

external link
115.

Brown MS et al. (1975) Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations.

external link
116.

Umans-Eckenhausen MA et al. (2001) Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.

external link
117.

Hasty AH et al. (2001) Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.

external link
118.

Brorholt-Petersen JU et al. (2001) LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy.

external link
119.

Chaves FJ et al. (2001) Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.

external link
120.

Brunzell JD et al. (1975) Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities.

external link
121.

IJzerman RG et al. (2001) Evidence for genetic factors explaining the association between birth weight and low-density lipoprotein cholesterol and possible intrauterine factors influencing the association between birth weight and high-density lipoprotein cholesterol: analysis in twins.

external link
122.

Buja LM et al. (1979) Cellular pathology of homozygous familial hypercholesterolemia.

external link
123.

Wen XY et al. (2003) Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans.

external link
124.

Deramo VA et al. (2003) Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients.

external link
125.

Hobbs HH et al. (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

external link
126.

EPSTEIN FH et al. (1959) Familial hypercholesterolemia, xanthomatosis and coronary heart disease.

external link
127.

Wilson JM et al. (1992) Ex vivo gene therapy of familial hypercholesterolemia.

external link
128.

Beekman M et al. (2003) Evidence for a QTL on chromosome 19 influencing LDL cholesterol levels in the general population.

external link
129.

Hedman M et al. (2005) Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study.

external link
130.

Newson AJ et al. (2005) Cascade testing in familial hypercholesterolaemia: how should family members be contacted?

external link
131.

None (2005) Cascade screening: whose information is it anyway?

external link
132.

Goldstein JL et al. (1975) Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism.

external link
133.

Chowdhury JR et al. (1991) Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

external link
134.

Brown MS et al. (1976) Receptor-mediated control of cholesterol metabolism.

external link
135.

None (1976) Inheritance of xanthomatosis and hyper-beta-lipoproteinaemia. A study of 7 large kindreds.

external link
136.

García-Otín AL et al. (2007) Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.

external link
137.

Varret M et al. (2008) Genetic heterogeneity of autosomal dominant hypercholesterolemia.

external link
138.

Brown MS et al. (1976) Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein.

external link
139.

Goldstein JL et al. (1977) Genetics of the LDL receptor: evidence that the mutations affecting binding and internalization are allelic.

external link
140.

Bilheimer DW et al. (1978) Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.

external link
141.

Johansen CT et al. (2010) Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.

external link
142.

Goldstein JL et al. (1978) Familial hypercholesterolemia: pathogenesis of a receptor disease.

external link
143.

Berger GM et al. (1978) Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia.

external link
144.

None (1979) A major locus for hyper-beta-lipoproteinemia with xanthomatosis.

external link
145.

Goldstein JL et al. (1979) The LDL receptor locus and the genetics of familial hypercholesterolemia.

external link
146.

Hummel M et al. (1990) Familial hypercholesterolemia in a rhesus monkey pedigree: molecular basis of low density lipoprotein receptor deficiency.

external link
147.

Goldstein JL et al. (1975) Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.

external link
148.

Leitersdorf E et al. (1989) Polymorphic DNA haplotypes at the LDL receptor locus.

external link
149.

Schuster H et al. (1989) Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia.

external link
150.

Edwards JA et al. (1978) Hyperlipidemia in a Lebanese community: difficulties in definition, diagnosis and decision on when to treat.

external link
151.

Humphries SE et al. (1985) A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis.

external link
152.

Leppert MF et al. (1986) A DNA probe for the LDL receptor gene is tightly linked to hypercholesterolemia in a pedigree with early coronary disease.

external link
153.

Armston AE et al. (1988) Diagnosis of familial hypercholesterolaemia using DNA probes for the low-density lipoprotein (LDL) receptor gene.

external link
154.

Houlston R et al. (1988) Lipoprotein (a) and coronary heart disease in familial hypercholesterolaemia.

external link
155.

Yamamoto T et al. (1986) Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

external link
156.

Scanu AM et al. (1988) Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor.

external link
157.

Hoeg JM et al. (1987) 3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia.

external link
158.

Hofmann SL et al. (1988) Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice.

external link
159.

Funahashi T et al. (1988) Mutations of the low density lipoprotein receptor in Japanese kindreds with familial hypercholesterolemia.

external link
160.

Kita T et al. (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

external link
161.

Innerarity TL et al. (1987) Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.

external link
162.

Brown MS et al. (1986) A receptor-mediated pathway for cholesterol homeostasis.

external link
163.

Goldstein JL et al. (1987) Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis.

external link
164.

Cuthbert JA et al. (1986) Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes.

external link
165.

Levy RA et al. (1986) Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.

external link
166.

Mabuchi H et al. (1986) Coronary ectasia in a homozygous patient with familial hypercholesterolemia.

external link
167.

Nora JJ et al. (1985) Familial hypercholesterolemia with "normal" cholesterol in obligate heterozygotes.

external link
168.

Bilheimer DW et al. (1985) Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.

external link
169.

Cai HJ et al. (1985) Homozygous familial hypercholesterolemic patients in China.

external link
170.

Ott J et al. (1974) Linkage studies in a large kindred with familial hypercholesterolemia.

external link
171.

Goldstein JL et al. (1973) Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.

external link
172.

Kwiterovich PO et al. (1974) Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

external link
173.

Goldstein JL et al. (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

external link
174.

Goldstein JL et al. (1975) Hyperlipidemia in coronary heart disease: a biochemical genetic approach.

external link
175.

Schrott HG et al. (1972) Familial hypercholesterolemia in a large indred. Evidence for a monogenic mechanism.

external link
176.

Higgins MJ et al. (1975) A new type of familial hypercholesterolaemia.

external link
177.

Fredrickson DS et al. (1967) Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

external link
178.

None (1969) Plasma lipoproteins: micellar models and mutants.

external link
179.

Slack J et al. (1968) Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis.

external link
180.

Hould F et al. (1969) Essential familial hypercholesterolemia with xanthomatosis.

external link
181.

Namboodiri KK et al. (1977) Segregation and linkage analyses of a large pedigree with hypertriglyceridemia.

external link
182.

None (1983) Portacaval shunt in familial hypercholesterolaemia.

external link
183.

Starzl TE et al. (1984) Heart-liver transplantation in a patient with familial hypercholesterolaemia.

external link
184.

Brown MS et al. (1981) Regulation of plasma cholesterol by lipoprotein receptors.

external link
185.

Miyake Y et al. (1981) Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.

external link
186.

Goldstein B et al. (1981) Interactions of low density lipoprotein receptors with coated pits on human fibroblasts: estimate of the forward rate constant and comparison with the diffusion limit.

external link
187.

Magnus P et al. (1981) Genetics of the low density lipoprotein receptor: II. Genetic control of variation in cell membrane low density lipoprotein receptor activity in cultured fibroblasts.

external link
188.

Maartmann-Moe K et al. (1981) Genetics of the low density lipoprotein receptor: III. Evidence for multiple normal alleles at the low density lipoprotein receptor locus.

external link
189.

Maartmann-Moe K et al. (1981) Genetics of the low density lipoprotein receptor: I. Low density lipoprotein receptor activity in cultured fibroblasts from subjects with or without familial hypercholesterolemia.

external link
190.

Harders-Spengel K et al. (1982) Difference in saturable binding of low density lipoprotein to liver membranes from normocholesterolemic subjects and patients with heterozygous familial hypercholesterolemia.

external link
191.

Tolleshaug H et al. (1983) The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor.

external link
192.

Goldstein JL et al. (1983) Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia.

external link
193.

McNamara DJ et al. (1983) Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes.

external link
194.

Bilheimer DW et al. (1983) Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

external link
195.

Hornick CA et al. (1983) Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.

external link
196.

Mabuchi H et al. (1983) Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.

external link
197.

Mabuchi H et al. (1978) Homozygous familial hypercholesterolemia in Japan.

external link
198.

Rose V et al. (1982) Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling.

external link
199.

Mabuchi H et al. (1981) Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.

external link
200.

Glueck CJ et al. (1980) Pancreatitis, familial hypertriglyceridemia, and pregnancy.

external link
201.

King ME et al. (1980) Plasma-exchange therapy of homozygous familial hypercholesterolemia.

external link
202.

Berg K et al. (1978) Linkage between familial hypercholesterolemia with xanthomatosis and the C3 polymorphism confirmed.

external link
203.

Sass C et al. (1995) Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia.

external link
204.

Tikkanen MJ et al. (1978) Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women.

external link
205.

Ishibashi S et al. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.

external link
206.

Betteridge DJ et al. () Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.

external link
207.

Deckelbaum RJ et al. (1977) Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.

external link
208.

Ishibashi S et al. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

external link
209.

Tonstad S et al. (1996) Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.

external link
210.

Summers RM et al. (1998) Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia.

external link
211.

Berg K et al. (1976) Linkage studies on familial hyperlipoproteinemia with xanthomatosis: normal lipoprotein markers and the C3 polymorphism.

external link
212.

Elston RC et al. (1976) Probable linkage between essential familial hypercholesterolemia and third complement component (C3).

external link
213.

OMIM.ORG article

Omim 605019 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz